This clinical study is evaluating a new treatment for PKD1 mutation-associated autosomal dominant polycystic kidney disease (ADPKD), a condition that results in kidney failure. The primary goal is to assess the safety and tolerability of the treatment in adults with confirmed PKD1 mutation-associated ADPKD.
Oct 02nd, 16th, 30th, Nov 13th, 27th, Dec 11th, Mar 05th
To Qualify, You Must
Age
Be 18 to 60 years old
Gender
Male or female
Physical Condition
Diagnosed with PKD1 mutation-associated ADPKD
Requirements
Have a BMI between 18 and 32kg/m2
Renumeration
There are no additional costs associated with participating in this research project, nor will you be
paid. All medication, tests and medical care required as part of the research project will be provided
to you free of charge.